Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 103

1.

INITIAL SYMPTOMATIC PITUITARY METASTASIS IN A PATIENT WITH PROSTATE FOAMY GLAND CARCINOMA: TAILORING SAFE AND EFFECTIVE THERAPY.

Prpić M, Fröbe A, Zadravec D, Pažanin L, Jakšić B, Bolanča A, Kusić Z.

Acta Clin Croat. 2015 Jun;54(2):243-8.

PMID:
26415325
2.

Randomized Phase II Trial Comparing Obinutuzumab (GA101) With Rituximab in Patients With Relapsed CD20+ Indolent B-Cell Non-Hodgkin Lymphoma: Final Analysis of the GAUSS Study.

Sehn LH, Goy A, Offner FC, Martinelli G, Caballero MD, Gadeberg O, Baetz T, Zelenetz AD, Gaidano G, Fayad LE, Buckstein R, Friedberg JW, Crump M, Jaksic B, Zinzani PL, Padmanabhan Iyer S, Sahin D, Chai A, Fingerle-Rowson G, Press OW.

J Clin Oncol. 2015 Oct 20;33(30):3467-74. doi: 10.1200/JCO.2014.59.2139. Epub 2015 Aug 17.

3.

[Clinical features in DLBCL and translocation BCL2/c-MYC "double hit" lymphoma].

Škunca Ž, Domimis M, Plninc-Peraica A, Jakšić B.

Acta Med Croatica. 2014 Jun;68(3):299-305. Croatian.

PMID:
26016222
4.

Sunitinib-induced thyrotoxicosis - a not so rare entity.

Jazvić M, Prpić M, Jukić T, Murgić J, Jakšić B, Kust D, Prgomet A, Bolanča A, Kusić Z.

Anticancer Res. 2015 Jan;35(1):481-5.

PMID:
25550591
5.

High-dose-rate brachytherapy and concurrent chemoradiotherapy followed by surgery for stage Ib-IIb cervical cancer: single institution experience.

Fröbe A, Jones G, Bokulić T, Mrčela I, Budanec M, Murgić J, Jakšić B, Prpić M, Bolanča A, Kusić Z.

Anticancer Res. 2014 Jul;34(7):3861-6.

PMID:
24982415
6.

Hypothyroidism as a predictive clinical marker of better treatment response to sunitinib therapy.

Kust D, Prpić M, Murgić J, Jazvić M, Jakšić B, Krilić D, Bolanča A, Kusić Z.

Anticancer Res. 2014 Jun;34(6):3177-84.

PMID:
24922691
7.

An old and simple solution for a new problem--more on clinical staging and evaluation of response in B-cell chronic lymphocytic leukaemia in the era of new therapies.

Jaksic O, Vitale B, Jaksic B.

Br J Haematol. 2014 Jun;165(5):737-40. doi: 10.1111/bjh.12793. Epub 2014 Feb 24. No abstract available.

PMID:
24611532
8.

Fludarabine plus alemtuzumab versus fludarabine alone in patients with previously treated chronic lymphocytic leukaemia: a randomised phase 3 trial.

Elter T, Gercheva-Kyuchukova L, Pylylpenko H, Robak T, Jaksic B, Rekhtman G, Kyrcz-Krzemień S, Vatutin M, Wu J, Sirard C, Hallek M, Engert A.

Lancet Oncol. 2011 Dec;12(13):1204-13. doi: 10.1016/S1470-2045(11)70242-X. Epub 2011 Oct 10.

PMID:
21992852
9.

[Longterm indolent course of pleomorphic mantle cell lymphoma with multiple chromosomal abnormalities].

Pazur M, Ostojić A, Jelić-Puskarić B, Kardum-Skelin I, Vrhovac R, Gasparov S, Trcić RL, Jaksić B.

Acta Med Croatica. 2011 Sep;65 Suppl 1:197-201. Croatian.

PMID:
23126052
10.

[Isolated myeloid sarcoma involving the mediastinum].

Jelić-Puskarić B, Kardum-Skelin I, Sustercić D, Pazur M, Vrhovac R, Radić-Kristo D, Gredelj-Simec N, Kovacević DO, Plasćak J, Gasparov S, Jaksić B.

Acta Med Croatica. 2011 Sep;65 Suppl 1:133-8. Croatian.

PMID:
23126041
11.

[Association of CD34 cell surface antigen expression with cytomorphological characteristics of acute promyelocytic leukemia blasts and clinical characteristics of patients: one center experience].

Ostojić A, Pazur M, Siftar Z, Paro MM, Jelić-Puskarić B, Gredelj-Simec N, Radić-Kristo D, Kardum-Skelin I, Vrhovac R, Jaksić B.

Acta Med Croatica. 2011 Sep;65 Suppl 1:67-74. Croatian.

PMID:
23126032
12.

[Diagnostic and prognostic significance of CD45 cell surface antigen expression in hematologic malignancies with main focus on acute leukemias].

Gredelj-Simec N, Jelić-Puskarić B, Ostojić A, Siftar Z, Fiala D, Kardum-Skelin I, Vrhovac R, Jaksić B.

Acta Med Croatica. 2011 Sep;65 Suppl 1:45-52. Croatian.

PMID:
23126029
13.

[Perception of cytology from the clinician standpoint].

Jaksić B.

Acta Med Croatica. 2011 Sep;65 Suppl 1:5-9. Croatian. No abstract available.

PMID:
23126022
14.

[Diagnosis and therapy for patients with essential thrombocythemia. Guidelines of Croatian Cooperative Group for hematologic disorders--KROHEM].

Labar B, Kusec R, Jaksić B, Skare-Librenjak L, Nacinović-Duletić A, Petricević-Sincić J, Carzavec D, Coha B, Gverić-Krecak V, Corović E, Lang N, Lojen-Nemet Z, Babok-Flegarić R; Croatian Cooperative Group for hematologic disorders.

Lijec Vjesn. 2010 Nov-Dec;132(11-12):333-9. Croatian.

PMID:
21294321
15.

New parameters of diploid histogram of image DNA cytometry and newly characterized types of nucleolar organizer region structures in defining the proliferative-kinetic index in chronic leukemic lymphoproliferative disorders.

Kardum-Skelin I, Jaksic O, Kolonic SO, Vrhovac R, Fabijanic I, Jelic-Puskaric B, Milas M, Jaksic B.

Anal Quant Cytol Histol. 2009 Oct;31(5):313-23.

PMID:
20701099
16.

T lymphoblastic leukaemia with an unusual Burkitt lymphoma morphology--a case report.

Pazur M, Jelić-Puskarić B, Planinc-Peraica A, Vrhovac R, Kardum-Skelin I, Jaksić B.

Coll Antropol. 2010 Jun;34(2):675-8.

PMID:
20698152
17.

Myeloid sarcoma involving the breast.

Jelić-Puskarić B, Ostojić-Kolonić S, Planinc-Peraica A, Obad-Kovacević D, Kardum-Skelin I, Jaksić B.

Coll Antropol. 2010 Jun;34(2):641-4.

PMID:
20698144
18.

Primary gastrointestinal non-Hodgkin lymphoma in adults: clinicopathologic and survival characteristics.

Radić-Kristo D, Planinc-Peraica A, Ostojić S, Vrhovac R, Kardum-Skelin I, Jaksić B.

Coll Antropol. 2010 Jun;34(2):413-7.

PMID:
20698111
19.

Serum immunoglobulins in non-Hodgkin's lymphoma patients.

Planinc-Peraica A, Kolonić SO, Radić-Kristo D, Dominis M, Jaksić B.

Coll Antropol. 2010 Jun;34(2):407-11.

PMID:
20698110
20.
21.

Flow cytometry immunophenotyping (FCI) of fine needle aspirates (FNAs) of lymph nodes.

Paro MM, Siftar Z, Kardum-Skelin I, Sustercić D, Nazor A, Flegar-Mestrić Z, Jaksić B.

Coll Antropol. 2010 Jun;34(2):359-65.

PMID:
20698103
22.

Serum levels of VEGF and bFGF in hypoxic patients with exacerbated COPD.

Pavlisa G, Pavlisa G, Kusec V, Kolonic SO, Markovic AS, Jaksic B.

Eur Cytokine Netw. 2010 Jun;21(2):92-8. doi: 10.1684/ecn.2010.0193. Epub 2010 May 27.

23.

Chronic lymphocytic leukemia: insights from lymph nodes & bone marrow and clinical perspectives.

Jaksić O, Kardum-Skelin I, Jaksić B.

Coll Antropol. 2010 Mar;34(1):309-13. Review.

PMID:
20432765
24.

An unusual presentation of Gaucher's disease: aortic valve fibrosis in a patient homozygous for a rare G377S mutation.

Perić Z, Kardum-Skelin I, Puskarić BJ, Letilović T, Vrhovac R, Jaksić B.

Coll Antropol. 2010 Mar;34(1):275-8.

PMID:
20432762
25.

Diffuse large B-cell lymphoma in patient after treatment of angioimmunoblastic T-cell lymphoma.

Skugor ND, Perić Z, Vrhovac R, Radić-Kristo D, Kardum-Skelin I, Jaksić B.

Coll Antropol. 2010 Mar;34(1):241-5.

PMID:
20432757
26.

Post-thaw viability of cryopreserved hematopoietic progenitor cell grafts: does it matter?

Vrhovac R, Perić Z, Jurenec S, Kardum-Skelin I, Jelić-Puskarić B, Jaksić B.

Coll Antropol. 2010 Mar;34(1):163-9.

PMID:
20432746
27.

Value of fine-needle aspiration cytology in diagnosis of Hodgkin's lymphoma and anaplastic large cell lymphoma: one centre experience.

Kolonić SO, Prasek-Kudrna K, Roso V, Radić-Kristo D, Planinc-Peraica A, Dzebro S, Kardum-Skelin I, Jaksić B.

Coll Antropol. 2010 Mar;34(1):75-9.

PMID:
20432736
28.

Dexamethasone compared to prednisolone for adults with acute lymphoblastic leukemia or lymphoblastic lymphoma: final results of the ALL-4 randomized, phase III trial of the EORTC Leukemia Group.

Labar B, Suciu S, Willemze R, Muus P, Marie JP, Fillet G, Berneman Z, Jaksic B, Feremans W, Bron D, Sinnige H, Mistrik M, Vreugdenhil G, De Bock R, Nemet D, Gilotay C, Amadori S, de Witte T; EORTC Leukemia Group.

Haematologica. 2010 Sep;95(9):1489-95. doi: 10.3324/haematol.2009.018580. Epub 2010 Apr 7.

29.

[Autologous stem cell transplantation in patients with relapsed or refractory Hodgkin's disease].

Minigo H, Vrhovac R, Kalac M, Jaksić B.

Acta Med Croatica. 2009 Jun;63(3):215-7. Croatian.

PMID:
19827348
30.

FOXP1 and BCL2 show similar immunoenzymatic pattern in bone marrow trephines of chronic lymphocytic leukemia patients.

Korać P, Vintar MG, Ajduković R, Kardum Paro MM, Jaksić B, Dominis M.

Appl Immunohistochem Mol Morphol. 2009 Dec;17(6):500-4. doi: 10.1097/PAI.0b013e3181a20307.

PMID:
19417623
31.

Intraluminal brachytherapy in the management of squamous carcinoma of the esophagus.

Frobe A, Jones G, Jaksić B, Bokulić T, Budanec M, Iva M, Stancić-Rokotov D, Hrabar D, Bolanca A, Rosenblatt E, Kusić Z.

Dis Esophagus. 2009;22(6):513-8. doi: 10.1111/j.1442-2050.2009.00958.x. Epub 2009 Mar 17.

PMID:
19302221
32.

Immunohistochemical analysis of ZAP-70 expression in chronic lymphocytic leukemia.

Korać P, Ajduković R, Kardum Paro MM, Jaksić B, Dominis M.

J Mol Histol. 2009 Feb;40(1):81-6. doi: 10.1007/s10735-009-9213-6. Epub 2009 Mar 7.

PMID:
19267204
33.

[Clinical and laboratory prognostic parameters for leukemic types of chronic lymphoproliferative diseases].

Kardum-Skelin I, Planinc-Peraica A, Ostojić Kolonić S, Radić-Kristo D, Milas M, Vrhovac R, Sustercić D, Minigo H, Jaksić B.

Acta Med Croatica. 2008 Oct;62(4):351-64. Croatian.

PMID:
19205412
34.

Prognostic significance of B-cell differentiation genes encoding proteins in diffuse large B-cell lymphoma and follicular lymphoma grade 3.

Borovecki A, Korać P, Nola M, Ivanković D, Jaksić B, Dominis M.

Croat Med J. 2008 Oct;49(5):625-35.

35.

[The disappearance of CD20 positive lymphocytes in the pleural effusion after intrapleural application of rituximab].

Kalac M, Kolonić SO, Kardum-Skelin I, Planinc-Peraica A, Siftar Z, Jaksić B.

Acta Med Croatica. 2007 Sep;61(4):425-7. Croatian.

PMID:
18044481
36.

Alemtuzumab compared with chlorambucil as first-line therapy for chronic lymphocytic leukemia.

Hillmen P, Skotnicki AB, Robak T, Jaksic B, Dmoszynska A, Wu J, Sirard C, Mayer J.

J Clin Oncol. 2007 Dec 10;25(35):5616-23. Epub 2007 Nov 5.

PMID:
17984186
37.

Role of angiogenesis in chronic lymphocytic leukemia.

Letilovic T, Vrhovac R, Verstovsek S, Jaksic B, Ferrajoli A.

Cancer. 2006 Sep 1;107(5):925-34. Review.

38.

[Microcellular lung carcinoma in patient with hepatosplenic T-cell lymphoma: a case report].

Kalac M, Ostojić S, Gasparov S, Planinc-Peraica A, Dominis M, Jaksić B.

Lijec Vjesn. 2006 Mar-Apr;128(3-4):76-8. Croatian.

PMID:
16808095
39.

More on prognostic significance of FLT3/ITD size in acute myeloid leukemia (AML).

Kusec R, Jaksic O, Ostojic S, Kardum-Skelin I, Vrhovac R, Jaksic B.

Blood. 2006 Jul 1;108(1):405-6; author reply 406. No abstract available.

40.

Primary mediastinal large B-cell lymphoma: a single-center study of clinicopathologic characteristics.

Kolonić SO, Dzebro S, Kusec R, Planinc-Peraica A, Dominis M, Jaksić B.

Int J Hematol. 2006 May;83(4):331-6.

PMID:
16757434
41.

Acute leukemia in patients with untreated chronic lymphocytic leukemia: a report of two cases with remarkably similar time cluster.

Pavlisa G, Kolonic SO, Minigo H, Kardum-Skelin I, Kardum-Paro MM, Jaksic B.

Leuk Lymphoma. 2006 May;47(5):950-2. No abstract available.

PMID:
16753890
42.

Efficacy and safety of linezolid compared with vancomycin in a randomized, double-blind study of febrile neutropenic patients with cancer.

Jaksic B, Martinelli G, Perez-Oteyza J, Hartman CS, Leonard LB, Tack KJ.

Clin Infect Dis. 2006 Mar 1;42(5):597-607. Epub 2006 Jan 25.

PMID:
16447103
43.

Pneumomediastinum as a complication to treatment of mediastinal (thymic) large B-cell lymphoma.

Pavlisa G, Planinc-Peraica A, Anic P, Kardum-Skelin I, Pavlisa G, Jaksic B.

Acta Radiol. 2005 Jul;46(4):371-3.

PMID:
16134313
44.

Humoral SPARC/osteonectin protein in plasma cell dyscrasias.

Turk N, Kusec R, Jaksic B, Turk Z.

Ann Hematol. 2005 May;84(5):304-10. Epub 2005 Jan 12.

PMID:
15645230
45.

[Presence of bcl-2 and p53 proteins in patients with non-Hodgkin's lymphoma at Zadar General Hospital].

Skunca Z, Gverić-Krecak V, Dominis M, Planinc-Peraica A, Jaksić B.

Acta Med Croatica. 2004;58(3):183-6. Croatian.

PMID:
15503680
47.

CD38 on B-cell chronic lymphocytic leukemia cells has higher expression in lymph nodes than in peripheral blood or bone marrow.

Jaksic O, Paro MM, Kardum Skelin I, Kusec R, Pejsa V, Jaksic B.

Blood. 2004 Mar 1;103(5):1968-9. No abstract available.

48.

[Occurrence of chronic B-cell lymphocytic leukemia in Hodgkin's disease: case report].

Turk N, Kusec R, Dominis M, Marusić-Vrsalović M, Jaksić B.

Lijec Vjesn. 2003 Jul-Aug;125(7-8):184-7. Croatian.

PMID:
14692092
49.

Bone marrow and peripheral blood hematopoietic reserve in patients with B-cell chronic lymphocytic leukemia.

Pejsa V, Kusec R, Petrovecki M, Jaksic O, Jaksic B, Boranic M.

Haematologica. 2003 Dec;88(12):1429-31. No abstract available.

50.

[Non-Hodgkin's lymphoma: clinical symptoms, therapy and prognosis in 37 patients].

Skunca Z, Gverić-Krecak V, Dominis M, Planinc-Peraica A, Jaksić B.

Acta Med Croatica. 2003;57(4):261-7. Croatian.

PMID:
14639859

Supplemental Content

Loading ...
Support Center